In conversation with....

Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin.Read the full article:Mechanisms of ageing: growth hormone, dietary restriction, and metforminContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective. Read the full article:Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.Read the full article:Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma

Rossella Nappi talks with The Lancet Diabetes & Endocrinology about cardiometabolic changes that occur during the menopausal transition and implications for women's health.Read the full Series:Menopause

Louise Baur talks with The Lancet Diabetes & Endocrinology about the prevalence and causes of child and adolescent obesity, and the need for personalised treatment approaches.Read the full article:Obesity in children and adolescents: epidemiology, causes, assessment, and management

Margherita Pizzato talks with The Lancet Diabetes & Endocrinology about the global epidemiological landscape of thyroid cancer based on GLOBOCAN estimates in 2020.Read the full article:The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020

Angela Titmuss talks with The Lancet Diabetes & Endocrinology about youth-onset type 2 diabetes among First Nations young people in northern Australia.Read the full article:Youth-onset type 2 diabetes among First Nations young people in northern Australia

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries.Read the full article:https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext

Philip Home talks with The Lancet Diabetes & Endocrinology about the insulin centenary and how insulin therapy might develop in the future.

Victoria Salem talks with The Lancet Diabetes & Endocrinology about how to improve female inclusion and participation in scientific medical conferences.

Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.

Rishi Caleyachetty talks with The Lancet Diabetes & Endocrinology about the need to revise ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk.

Thomas Robinson talks with The Lancet Diabetes & Endocrinology about the Stanford GOALS randomised controlled trial in Latinx children with overweight or obesity. 

Adrian Martineau talks with The Lancet Diabetes & Endocrinology about how vitamin D supplementation can reduce the risk of acute respiratory infections.

William Kraus talks with The Lancet Diabetes & Endocrinology about how calorie restriction can reduce cardiometabolic risk even in young, healthy, non-obese adults.

Hiddo Lambers Heerspink talks with The Lancet Diabetes & Endocrinology about his work on changes in albuminuria and subsequent effect on kidney disease.

Mark Atkinson and Bart Roep join The Lancet Diabetes & Endocrinology to discuss a new Series on immune-based therapies for type 1 diabetes.

Series authors Annewieke van den Beld, Bu Yeap, Robin Peeters, and Zaki Hassan-Smith discuss how the endocrine system changes with age and the implications for healthy ageing.

Mohammed Ali talks to The Lancet Diabetes & Endocrinology about the cardiovascular and renal burdens of prediabetes in the USA.

Richard Oram discusses a study which uses UK Biobank data to look at the frequency of type 1 diabetes across the first six decades of life.

Michael Zimmerman talks about the effect of iodine supplementation in pregnant women on child development.

Moffat Nyirenda talks about the challenges facing diabetes in sub-Saharan Africa, as highlighted in a new Commission.

Martin Reincke discusses outcomes after adrenalectomy for unilateral primaryaldosteronism.

Two authors of papers on bariatric surgery in adolescents, Thomas Inge and Torsten Olbers, discuss their work, published in The Lancet Diabetes and Endocrinology.

Professor Mark Hanson, Director of the Institute of Developmental Sciences at the University of Southampton, discusses the society and policy changes needed to tackle the growing epidemic of maternal obesity worldwide.

Professor Paul Little talks about the PoWER+ trial, a system aimed at cost-effective, internet-based support for weight loss.

Dr Francesco Zaccardi discusses an article about hospital admissions for hypoglycaemia in England from 2005 to 2015.

Dr. Justin White discusses neighbourhood effects and how to research them

Ellen Flint and Caroline Brogan discuss the effect of active commuting on BMI and obesity.

David Beran discusses the challenges faced around the world to accessing insulin.

Barry Popkin discusses how public health measures globally need to address sugar content in beverages and food.

Lucilla Poston discusses results of the UPBEAT trial, which tested whether an intensive lifestyle intervention in obese women during pregnancy can reduce the incidence of gestational diabetes and large-for-gestational-age babies.

How do different methods for diagnosing diabetes affect estimates of prevalence and how is this likely to affect global estimates of this disease?

Does smoking cessation affect glycaemic control in people with diabetes?

Alexandra Papaioannou and John Schousboe discuss the pros and cons of expanding diagnostic criteria for osteoporosis.

Dick de Zeeuw discusses a trial looking at the effect of statins on renal function.

Lawrence Phillips talks about a study looking at the effects of a lifestyle programme on diabetes incidence and weight loss in a real-world population in the USA.

Edward Gregg from the US Centers for Disease Control discusses the rise in US diabetes incidence, and a concurrent fall in mortality from diabetes.

John Deanfield discusses lifetime changes in BMI and cardiovascular risk.

John Wentworth and Paul O'Brien discuss a randomized trial of bariatric surgery for overweight, non-obese people with type 2 diabetes.

Dr Rowan Gillies joins Natalie Harrison to discuss surgery for people with diabetes in low-income and middle-income countries.

Norbert Stefan discusses a small but positive trial of a new drug in people with non-alcoholic fatty liver disease.

Mark Bolland discusses the results of a sequential trial meta-analysis of the effects of vitamin D supplementation on skeletal, vascular, and cancer outcomes.

Michael Nauck discusses incretin-based drugs and pancreatitis risk.

Ambady Ramachandran discusses using text messaging to prevent diabetes in men at high risk of developing the disease.

Rachel Whitmer discusses a dementia risk score for people with type 2 diabetes.

Anna Peeters discusses diabetes and risk of physical disability in adults.

Deputy Editor Sarah Allan discusses the contents of a special preview of The Lancet Diabetes & Endocrinology, as well as plans for the journal's launch in September.

Anna Nordenstrom discusses the success of a newborn screening programme in Sweden for congenital adrenal hyperplasia.